Open Actively Recruiting

Long-Term Follow-Up Safety and Efficacy Study in Participants with Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Eligibility

Minimum Age
N/A
Maximum Age
N/A

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
23-001203
Category
Genetic and Rare Diseases
Contact
UMMULWARA QASIM
Location
  • UCLA Westwood